Second Messenger Action, cAMP & CGMP

Download as pdf or txt
Download as pdf or txt
You are on page 1of 27

GENERAL SCHEME OF SECOND MESSENGER ACTION

NUCLEOTIDES- cAMP & cGMP


GENERAL FEATURES OF SECOND MESSENGERS
Are intracellular messengers that have some properties in common:

1. They can be synthesized/released and broken down again in specific reactions


by enzymes or ion channels. The hormone must appropriately effect the
enzymes of synthesis and/or degradation of the mediator

e.g. Adenylate cyclase catalyses synthesis of cAMP, while cyclic nucleotide


phosphodiesterase (PDE) inactivates cAMP

2. An appropriate temporal relationship must exist among the hormone, mediator


and hormonal effect.
Some (like Ca2+) can be stored in special organelles and quickly released when
needed.

3. The hormone must induce elevated levels of the mediator. Their production and
destruction can be localized, enabling the cell to limit space and time of signal
activity.

4. The mediator or its analog must mimic the action of the hormone, which cannot
enter the cell.

5. If drugs are available to modulate the endogenous level of the mediator, they
should also mimic or inhibit, as appropriate the effects of the hormone.
SECOND MESSENGERS
• Relay signals received at receptors on the
cell surface to target molecules in the
cytosol or nucleus.

• In addition they serve to greatly amplify the


strength of the signal.

• Binding of a ligand to a single receptor at


the cell surface may end up causing
massive changes in the biochemical
activities within the cell.
cAMP

The cAMP signal transduction contains 5 main characters:

• stimulative hormone receptor (Rs) or inhibitory hormone receptor (Ri)


• Stimulative regulative G-protein (Gs) or inhibitory regulative G-protein (Gi)
• Adenylyl cyclase
• Protein Kinase A (PKA)
• cAMP phosphodiesterase.

• Stimulative regulative G-protein is a G-protein linked to stimulative hormone


receptor (Rs)

• and its α subunit upon activation could stimulate the activity of an enzyme or
other intracellular metabolism.

• On the contrary, inhibitory regulative G-protein is linked to an inhibitory


hormone receptor

• and its α subunit upon activation could inhibit the activity of an enzyme or
other intracellular metabolism.
cAMP
• The Adenylyl cyclase is a transmembrane
glycoprotein that catalyzes ATP to form
cAMP with the help of cofactor Mg2+ or
Mn2+.
• Cyclic AMP (cAMP)- is synthesized from
ATP by the action of the enzyme adenylyl
cyclase.

• The cAMP produced is a second messenger


in cellular metabolism and is an allosteric
activator to Protein kinase A.
cAMP
• Protein kinase A is an important enzyme in cell
metabolism due to its ability to regulate cell
metabolism:

• by phosphorylating specific committed enzymes


in the metabolic pathway

• and it can also regulate specific gene expression

• cellular secretion

• membrane permeability.
Protein kinase A
• The protein enzyme contains two catalytic subunits and
two regulatory subunits.

• When there is no cAMP,the complex is inactive.

• When cAMP binds to the regulatory subunits, their


conformation is altered,

• causing the dissociation of the regulatory subunits, which


activates protein kinase A and allows further biological
effects.

• cAMP phosphodiesterase is an enzyme that can degrade


cAMP to 5'-AMP, which will terminate the signal.
cAMP
• HORMONES THAT USE cAMP:
• Epinephrine and norepinephrine
• Glucagon
• Luteinizing hormone
• follicle stimulating hormone,
• thyroid-stimulating hormone
• Calcitonin
• parathyroid hormone
• antidiuretic hormone
Protein kinase A

• Binding of the hormone to its receptor activates a G


protein which, in turn, activates adenylyl cyclase.

• The resulting rise in cAMP turns on the appropriate


response in the cell by either/ or:

1. changing the molecular activities in the cytosol, often


using Protein Kinase A (PKA) — a cAMP-dependent protein
kinase that phosphorylates target proteins

2. turning on a new pattern of gene transcription.


Protein kinase A
• The cyclic AMP then goes on to activate specific
proteins.

• Some ion channels, for example, are gated by


cyclic AMP.

• But an especially important protein activated by


cyclic AMP is protein kinase A

• which goes on to phosphorylate certain cellular


proteins.

• The scheme below shows how cyclic AMP


activates protein kinase A.
EXAMPLE : MODE OF ACTION OF PEPTIDE HORMONE

• Glucagon binds its receptor in the plasma membrane of target cells


e.g. hepatocytes.

• Bound receptor interacts with and, through a set of G proteins, turns


on adenylate cyclase, which is also an integral membrane protein.

• Activated adenylate cyclase begins to convert ATP to cyclic AMP,


resulting in an elevated intracellular concentration of cAMP.

• High levels of cAMP in the cytosol make it probable that protein kinase
A will be bound by cAMP and therefore catalytically active.

• Active protein kinase A "runs around the cell" adding phosphates to


other enzymes, thereby changing their conformation and modulating
their catalytic activity - the cell has been changed.

• Levels of cAMP decrease due to destruction by


cAMP-phosphodiesterase and the inactivation of adenylate cyclase.
cAMP
• HORMONES THAT USE PROTEIN KINASE:
• Insulin
• growth hormone
• Prolactin
• Oxytocin
• Erythropoietin
• several growth factors
cGMP
Cyclic GMP is synthesized from the nucleotide GTP using the
enzyme guanylyl cyclase.

• Cyclic GMP serves as the second messenger for

• atrial natriuretic peptide (ANP)

• nitric oxide (NO)

• response of the rods of the retina to light.

• Some of the effects of cGMP are mediated through Protein


Kinase G (PKG)

• a cGMP-dependent protein kinase that phosphorylates


target proteins in the cell.
Effects of cGMP
• cGMP is a common regulator of ion channel conductance,
glycogenolysis, and cellular apoptosis.

• It also relaxes smooth muscle tissues. In blood vessels, relaxation of


vascular smooth muscles lead to vasodilation and increased blood
flow.

• cGMP is a secondary messenger in phototransduction in the eye. In


the photoreceptors of the mammalian eye, the presence of light
activates phosphodiesterase, which degrades cGMP.

• The calcium ion channels in photoreceptors are cGMP-gated, so


degradation of cGMP causes calcium channels to close,

• which leads to the hyperpolarization of the photoreceptor's plasma


membrane and ultimately to visual information being sent to the brain
Protein kinase G
• cGMP is involved in the regulation of some
protein-dependent kinases.

• For example, PKG (protein kinase G) is a dimer consisting


of one catalytic and one regulatory unit,

• with the regulatory units blocking the active sites of the


catalytic units.

• cGMP binds to sites on the regulatory units of PKG and


activates the catalytic units, enabling them to
phosphorylate their substrates.

• Unlike with the activation of PKA, the PKG is activated but


the catalytic and regulatory units do not disassociate.
Degradation of cGMP
• Numerous cyclic nucleotide
phosphodiesterases (PDE) can degrade
cGMP by hydrolyzing cGMP into 5'-GMP.

• PDE 5, -6 and -9 are cGMP-specific while


PDE1, -2, -3, -10 and -11 can hydrolyse both
cAMP and cGMP.

• Phosphodiesterase inhibitors prevent the


degradation of cGMP, thereby enhancing
and/or prolonging its effects.

You might also like